While many members in the CF field have been resistant to the concept that the CF heterozygote may harbor dysfunction since CF heterozygotes do not display a fully developed CF disease phenotype, correction of a ΔF-CFTR bearing homozygote to a ΔF-CFTR bearing heterozygote would control CF disease. The gene discussed is CFTR; the disease is cystic fibrosis.